First Trust Advisors LP Sangamo Therapeutics, Inc Transaction History

First Trust Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $3.38 Million - $4.2 Million	-331,982 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.88 - $17.05 $1.67 Million - $2.61 Million	153,352 Added 85.85%	331,982 $4.16 Million
Q4 2020 Feb 02, 2021	BUY	$9.23 - $18.18 $1.65 Million - $3.25 Million	178,630 New	178,630 $2.79 Million
Q4 2019 Feb 03, 2020	SELL	$8.03 - $11.7 $841,311 - $1.23 Million	-104,771 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$9.05 - $12.22 $948,177 - $1.28 Million	104,771 New	104,771 $948,000
Q2 2019 Jul 30, 2019	SELL	$8.75 - $13.03 $282,222 - $420,269	-32,254 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$7.72 - $12.81 $628,462 - $1.04 Million	-81,407 Reduced 71.62%	32,254 $308,000
Q4 2018 Feb 07, 2019	BUY	$9.51 - $16.6 $355,141 - $619,910	37,344 Added 48.93%	113,661 $1.31 Million
Q3 2018 Oct 25, 2018	SELL	$13.05 - $19.05 $1.67 Million - $2.44 Million	-128,233 Reduced 62.69%	76,317 $1.29 Million
Q2 2018 Aug 02, 2018	BUY	$13.9 - $19.8 $2.84 Million - $4.05 Million	204,550 New	204,550 $2.91 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.